Investment Announcement 1 Oct 2025 Claret Capital Partners Announces €10M Growth Funding in Yseop to Scale Generative AI Platform for Life Sciences and Pharma View Claret Capital Partners Announces €10M Growth Funding in Yseop to Scale Generative AI Platform for Life Sciences and Pharma
Claret Insight 30 Sep 2025 How to (and How Not to) Raise Venture Debt (and maybe even Equity…) View How to (and How Not to) Raise Venture Debt (and maybe even Equity…)
Claret News 17 Sep 2025 Claret Capital Partners announces second close of the CEGCF IV (“Fund IV”) at over €350 million to invest in tech and life sciences View Claret Capital Partners announces second close of the CEGCF IV (“Fund IV”) at over €350 million to invest in tech and life sciences
Investment Announcement 17 Sep 2025 Claret Capital Partners backs SaaSrooms to accelerate growth View Claret Capital Partners backs SaaSrooms to accelerate growth
Portfolio News 9 Sep 2025 Cytora acquired by Applied Systems accelerating the shared vision of delivering the Digital Roundtrip of Insurance View Cytora acquired by Applied Systems accelerating the shared vision of delivering the Digital Roundtrip of Insurance
Investment Announcement 27 Aug 2025 Claret Capital Partners invests €10M in Mindler to fuel growth through strategic M&A and market expansion View Claret Capital Partners invests €10M in Mindler to fuel growth through strategic M&A and market expansion
Claret Insight 13 Aug 2025 AI-Driven Surgical Robotics: The New Standard View AI-Driven Surgical Robotics: The New Standard
Portfolio News 22 Jul 2025 Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis View Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis